Aphex BioCleanse Systems (Aphex BioCleanse Systems) Debt-to-EBITDA : 0.00 (As of . 20)

View and export this data going back to . Start your Free Trial

What is Aphex BioCleanse Systems Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Aphex BioCleanse Systems's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. Aphex BioCleanse Systems's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. Aphex BioCleanse Systems's annualized EBITDA for the quarter that ended in . 20 was $0.00 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Aphex BioCleanse Systems's Debt-to-EBITDA or its related term are showing as below:

SNST's Debt-to-EBITDA is not ranked ^*
in the Consumer Packaged Goods industry.
Industry Median: 2.18
* Ranked among companies with meaningful Debt-to-EBITDA only.

Aphex BioCleanse Systems Debt-to-EBITDA Historical Data

The historical data trend for Aphex BioCleanse Systems's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aphex BioCleanse Systems Debt-to-EBITDA Chart

Aphex BioCleanse Systems Annual Data

Trend

Debt-to-EBITDA

Aphex BioCleanse Systems Quarterly Data

Debt-to-EBITDA

Competitive Comparison of Aphex BioCleanse Systems's Debt-to-EBITDA

For the Household & Personal Products subindustry, Aphex BioCleanse Systems's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aphex BioCleanse Systems's Debt-to-EBITDA Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Aphex BioCleanse Systems's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Aphex BioCleanse Systems's Debt-to-EBITDA falls into.

Aphex BioCleanse Systems Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Aphex BioCleanse Systems's Debt-to-EBITDA for the fiscal year that ended in . 20 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(	+	)	/	N/A
	=	N/A

Aphex BioCleanse Systems's annualized Debt-to-EBITDA for the quarter that ended in . 20 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(	+	)	/	0
	=	N/A

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (. 20) EBITDA data.

Aphex BioCleanse Systems (OTCPK:SNST) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Aphex BioCleanse Systems Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Aphex BioCleanse Systems's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Aphex BioCleanse Systems (Aphex BioCleanse Systems) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Aphex BioCleanse Systems Inc (OTCPK:SNST) » Definitions » Debt-to-EBITDA

Traded in Other Exchanges

N/A

Address

1820 State Road 13, Unit 11-43, Saint Johns, FL, USA, 32259

Website

https://www.aphexus.com

Aphex BioCleanse Systems Inc is a United States-based company that provides sanitization solutions. It develops and manufactures non-alcohol, non-toxic, and hydrogen-based disinfecting technology. The company produces proprietary hydrogen-based disinfectant and pesticide products known as Hy-IQ Water.